Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-News: AlzChem Group AG posts sales and earnings for the first nine months of 2019 at previous year's level


DGAP-News: AlzChem Group AG / Key word(s): Quarterly / Interim Statement/9 Month figures
AlzChem Group AG posts sales and earnings for the first nine months of 2019 at previous year's level
14.11.2019 / 06:30
The issuer is solely responsible for the content of this announcement.


AlzChem Group AG posts sales and earnings for the first nine months of 2019 at previous year's level


Trostberg, November 14, 2019 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, was able to confirm the previous year's level in both sales and earnings in the first nine months of 2019. Group sales in the reporting period amounted to EUR 287.7 million (9M 2018: EUR 287.2 million). The third quarter made a significant contribution with a sales increase of 8.1% to EUR 99.4 million. Over the nine-month period, a slight decline in sales in the Specialty Chemicals segment (-4.9%) was offset by a significant increase in sales in the Basics & Intermediates segment (+7.5%). The highlight of the third quarter of 2019 was the official commissioning of the new Creamino(R) plant at the Trostberg site in mid-September. Production capacity, which has tripled to around 21,000 tons, is now gradually being utilized in line with expected market growth.

On the earnings side, AlzChem successfully passed on significant cost increases (including for raw materials and personnel) through price adjustments (+3.0%). In addition, the product portfolio was further developed towards more complex and thus more high-priced products. Overall, AlzChem achieved earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 41.4 million (9M 2018: EUR 41.3 million), equivalent to an EBITDA margin of 14.4% (9M 2018: 14.4%). Consolidated net income for the period amounted to EUR 17.0 million, compared with EUR 20.4 million in the previous year. This was due to high extraordinary additions to pension provisions due to sharply falling interest rates.

For 2019 as a whole, AlzChem is forecasting consolidated sales of between EUR 375.0 million and EUR 385.0 million (2018: EUR 375.2 million) and adjusted EBITDA of between EUR 46.5 million and EUR 51.9 million (2018: EUR 49.4 million).

The detailed quarterly statement is available for download on the website www.alzchem.com under Investor Relations/Publications/Financial Reports.

About AlzChem
The AlzChem Group is a vertically integrated manufacturer of chemical products based on the so-called NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The Group has a leading position in select niche markets. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,560 employees at four sites in Germany and three other sites abroad.



14.11.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: [email protected]
Internet: www.alzchem.com
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 912649

 
End of News DGAP News Service

912649  14.11.2019 

fncls.ssp?fn=show_t_gif&application_id=912649&application_name=news&site_id=sharewise

AlzChem Group AG Stock

€49.00
2.300%
There is an upward development for AlzChem Group AG compared to yesterday, with an increase of €1.10 (2.300%).

Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments